Latest Headlines
-
Pulsenmore Receives FDA De Novo Marketing Authorization For Home-Use Prenatal Ultrasound, Pioneering A New Era Of Prenatal Care In The U.S.
11/3/2025
Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for the Pulsenmore ES, a home-use prenatal ultrasound platform that enables expectant mothers to perform guided scans at home interpreted by remote physicians.
-
Withings' U-Scan Brings Urine Analysis Into The Home
10/29/2025
After more than seven years of research and development, Withings, a pioneer in connected health, launches U-Scan, its most ambitious innovation to date - a miniaturized urine analysis laboratory that integrates advanced chemistry, optics, and artificial intelligence directly into the toilet environment.
-
Frontline Healthcare Partners Announces Acquisition Of Integracare Inc.
10/22/2025
Frontline Healthcare Partners ("Frontline"), a private equity firm exclusively focused on investing in leading distributed healthcare businesses, announced today that it has acquired Integracare Inc. ("Integracare"), a leading private-pay home care company in Ontario, Canada.
-
BD Simplifies At-Home HPV Testing To Broaden Access To Cervical Cancer Screening Outside United States
10/22/2025
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States.
-
Zero Candida Achieves Design Freeze And Begins Prototype Production Of ZC-001 Therapeutic Device
10/20/2025
Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a FemTech medical device company focused on revolutionizing women's health, is pleased to announce that it has commenced prototype production following the design freeze of ZC-001, the first AI-enabled therapeutic device integrating blue light therapy, targeted drug delivery, and wireless diagnostics for the personalized treatment of Vulvo-Vaginal Candidiasis (VVC).
-
Alora Healthcare Systems Earns ACHC Product Certification For Home Health, Home Care, And Hospice Software
10/14/2025
Alora Healthcare Systems, a leading provider of cloud-based software for care at home agencies, announced that its Home Health Software, Home Care Software, and Hospice Software platforms have each earned Product Certification from the Accreditation Commission for Health Care (ACHC).
-
Homecare Homebase Launches Innovative AI-Driven Tools
9/30/2025
Homecare Homebaseā (HCHB), the leading software for home-based care, has launched three new automation and AI-driven tools.
-
IntellaTriage Launches Integration With Epic, Again Elevating After-Hours Care With Seamless Interoperability
9/25/2025
IntellaTriage, the nation's leading provider of nurse-first after-hours triage solutions for hospice and home health organizations, has announced a groundbreaking integration between IntellaHub, its proprietary triage platform, and Epic, one of the most widely adopted electronic medical record (EMR) systems in the country.
-
Heartline Delivers Daily Peace Of Mind For America's Family Caregivers
9/23/2025
Heartline today announced the nationwide launch of its AI-powered home health assistant, built to give families peace of mind with consistent, daily health check-ins.
-
DwellSafe Launches AI-Powered Home Scans To Reduce Falls And Hospital Readmissions For Aging Adults
9/22/2025
DwellSafe, an AgeTech innovator combining AI and clinician insight to prevent falls and hospital readmissions, today announced the launch of its AI-powered home-safety and accessibility platform which helps older adults, people with disabilities, and post-acute patients live more safely and independently.